Article
MYBPC3 polymorphism is a modifier for expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.
Biochemical and biophysical research communications - 8 Apr 2005
Wang Ping, Zou Yubao, Fu Chunyan, Zhou Xianliang, Hui Rutai
Abstract excerpt
Clinical phenotype of hypertrophic cardiomyopathy exhibits significant inter- and intra-familial heterogeneities. To test if MYBPC3 polymorphism could modify the expression of cardiac hypertrophy, 226 patients with hypertrophic cardiomyopathy and 226 age- and sex-matched controls were recruited according to the diagnostic criteria of WHO. Genotyping was completed by using PCR, restrictive enzyme digestion, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
